China (Mainland)
Premiumsupplier
Ozenoxacin Intermediate CAS 103877-51-6 CAS NO.103877-51-6
- Min.Order: 1 Kilogram
- Payment Terms: L/C,T/T,Other
- Product Details
Keywords
- Ozenoxacin Intermediate
- 103877-51-6
- C16h16clno3
Quick Details
- ProName: Ozenoxacin Intermediate CAS 103877-51-...
- CasNo: 103877-51-6
- Molecular Formula: C16h16clno3
- Appearance: white Powder
- Application: Intermediates and materials
- DeliveryTime: as customers request
- PackAge: 1-5KG/Tin or Bag,25KG/Drum, 200KG/Drum
- Port: any port in China
- ProductionCapacity: 1000 Metric Ton/Year
- Purity: >99%
- Storage: Refrigerator and seal.
- Transportation: by sea or by air
- LimitNum: 1 Kilogram
Superiority
| 1)Quick Response Within 12 hours; |
| 2)Quality Guarantee: All products are strictly tested by our QC, confirmed by QA and approved by third party lab in China, USA, Canada, Germany, UK, Italy, France etc. |
| 3) OEM/ODM Available; |
| 4) Reasonable & Competitive Price; |
| 5) Fast Delivery: Samples from stock; bulk products within 7 days; |
| 6) Professional Documents for Your Clearance; |
| 7) Economic Freight Save Your Cost; |
| 8) All your money be refund immediately if quality issue happens. |
Details
Product information
| Product Name: | ethyl 7-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate |
| Synonyms: | ethyl 7-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate;ethyl 7-chloro-1-cyclopropyl-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate;ethyl 7-chloro-1-cyclopropyl-8-methyl-4-oxo-quinoline-3-carboxylate;7-Chloro-1-cyclopropyl-8-methyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid ethyl ester;7-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate;3-Quinolinecarboxylic acid, 7-chloro-1-cyclopropyl-1,4-dihydro-8-methyl-4-oxo-, ethyl ester;Ethyl 7-chloro-1-cyclopropyl-8-methyl-4-oxo-quinoline-3-carboxylate fandachem;7- Chloro-1-cyclopropyl-8-methyl-4-oxyquinoline-3-carboxylate, ethyl ester |
| CAS: | 103877-51-6 |
| MF: | C16H16ClNO3 |
| MW: | 305.76 |
| EINECS: | 600-496-4 |
Ozenoxacin is a new type of non-fluoroquinolone antibacterial drug developed by Ferrer for the treatment of pustular dermatitis and other skin infections. By inhibiting DNA gyrase and topoisomerase IV, it is used as a cream (10g , 1%) to treat bacterial skin infections, including Gram-positive skin and soft tissue infections. At present, the compound has successfully completed the Phase III clinical trials for the treatment of adult Chemicalbook and pustular dermatitis in children, showing stronger antibacterial activity, safety and tolerability. Ozefloxacin was launched in Japan in July 2014 and was approved in September 2015 for the treatment of acne and skin infections (10g, 2%, gel). Ozefloxacin has a long chemical synthesis route. In its synthesis process, the following compound is an important Ozefloxacin intermediate.
Product Name |
Ethyl 7-chloro-8-methyl-4-oxo- 1,4-dihydroquinoline-3-carboxylate |
CAS No. | 103877-51-6 | |||||
Batch No. |
19031501 | Mfg. Date |
2019.03.15 | |||||
Report Date |
2019.03.21 | Exp. Date |
2021.03.14 | |||||
Quantity |
800 g | Quality Standard |
Enterprise Standard |
|||||
Tests |
SPECIFICATIONS |
RESULTS |
||||||
Appearance |
White to yellow powder |
Light yellow powder |
||||||
Related substances |
Total impurities ≤2.0% |
1.189% | ||||||
Max unknown single impurity ≤1.0% |
0.718% | |||||||
loss on drying |
≤1.0% | 0.32% | ||||||
Conclusion |
. The results conform to the Enterprise standard |
|||||||